213 related articles for article (PubMed ID: 32493234)
1. Productivity costs from a dengue episode in Asia: a systematic literature review.
Hung TM; Shepard DS; Bettis AA; Nguyen HA; McBride A; Clapham HE; Turner HC
BMC Infect Dis; 2020 Jun; 20(1):393. PubMed ID: 32493234
[TBL] [Abstract][Full Text] [Related]
2. Economic cost and burden of dengue in the Philippines.
Edillo FE; Halasa YA; Largo FM; Erasmo JNV; Amoin NB; Alera MTP; Yoon IK; Alcantara AC; Shepard DS
Am J Trop Med Hyg; 2015 Feb; 92(2):360-366. PubMed ID: 25510723
[TBL] [Abstract][Full Text] [Related]
3. The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.
Iragorri N; de Oliveira C; Fitzgerald N; Essue B
Appl Health Econ Health Policy; 2021 May; 19(3):325-341. PubMed ID: 33368032
[TBL] [Abstract][Full Text] [Related]
4. Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan.
Luh DL; Liu CC; Luo YR; Chen SC
J Infect Public Health; 2018; 11(2):215-223. PubMed ID: 28757293
[TBL] [Abstract][Full Text] [Related]
5. Approaches to refining estimates of global burden and economics of dengue.
Shepard DS; Undurraga EA; Betancourt-Cravioto M; Guzmán MG; Halstead SB; Harris E; Mudin RN; Murray KO; Tapia-Conyer R; Gubler DJ
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3306. PubMed ID: 25412506
[TBL] [Abstract][Full Text] [Related]
6. Economic and disease burden of dengue in Southeast Asia.
Shepard DS; Undurraga EA; Halasa YA
PLoS Negl Trop Dis; 2013; 7(2):e2055. PubMed ID: 23437406
[TBL] [Abstract][Full Text] [Related]
7. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
[TBL] [Abstract][Full Text] [Related]
9. Impact of a Nonfatal Dengue Episode on Disability-Adjusted Life Years: A Systematic Analysis.
Zeng W; Halasa-Rappel YA; Durand L; Coudeville L; Shepard DS
Am J Trop Med Hyg; 2018 Dec; 99(6):1458-1465. PubMed ID: 30277202
[TBL] [Abstract][Full Text] [Related]
10. The economic burden of dengue fever in the Kingdom of Saudi Arabia.
Akbar NA; Assiri AM; Shabouni OI; Alwafi OM; Al-Raddadi R; H Alzahrani M; Azhar EI; Amir A; Aljiffri AM; Althaqafi AO
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008847. PubMed ID: 33253181
[TBL] [Abstract][Full Text] [Related]
11. Household and Hospitalization Costs of Pediatric Dengue Illness in Colombo, Sri Lanka.
Sonali Fernando E; Headley TY; Tissera H; Wilder-Smith A; De Silva A; Tozan Y
Am J Trop Med Hyg; 2021 May; 105(1):110-116. PubMed ID: 33999848
[TBL] [Abstract][Full Text] [Related]
12. [The cost of schizophrenia: a literature review].
Charrier N; Chevreul K; Durand-Zaleski I
Encephale; 2013 May; 39 Suppl 1():S49-56. PubMed ID: 23351935
[TBL] [Abstract][Full Text] [Related]
13. Total economic cost and burden of dengue in Nicaragua: 1996-2010.
Wettstein ZS; Fleming M; Chang AY; Copenhaver DJ; Wateska AR; Bartsch SM; Lee BY; Kulkarni RP
Am J Trop Med Hyg; 2012 Oct; 87(4):616-22. PubMed ID: 22890033
[TBL] [Abstract][Full Text] [Related]
14. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
15. Cost and disease burden of dengue in Cambodia.
Beauté J; Vong S
BMC Public Health; 2010 Aug; 10():521. PubMed ID: 20807395
[TBL] [Abstract][Full Text] [Related]
16. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M
Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330
[TBL] [Abstract][Full Text] [Related]
17. The global economic burden of dengue: a systematic analysis.
Shepard DS; Undurraga EA; Halasa YA; Stanaway JD
Lancet Infect Dis; 2016 Aug; 16(8):935-41. PubMed ID: 27091092
[TBL] [Abstract][Full Text] [Related]
18. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
Png ME; Yoong J; Phan TP; Wee HL
BMC Public Health; 2016 Feb; 16():153. PubMed ID: 26880337
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of dengue in Mexico considering reported cases for 2012 to 2016.
Zubieta-Zavala A; López-Cervantes M; Salinas-Escudero G; Ramírez-Chávez A; Castañeda JR; Hernández-Gaytán SI; López Yescas JG; Durán-Arenas L
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006938. PubMed ID: 30550569
[TBL] [Abstract][Full Text] [Related]
20. Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study.
Huy R; Wichmann O; Beatty M; Ngan C; Duong S; Margolis HS; Vong S
BMC Public Health; 2009 May; 9():155. PubMed ID: 19473500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
